Overview
- The stock fell below its $135 IPO price this week, first dipping on Wednesday, and continued sliding into the $120s and $130s despite a high‑profile Starship test that failed to move the market.
- A tiny public float after the record $75 billion listing left the stock highly sensitive to retail buying, options hedging and fast index‑related ETF flows that amplified early gains and then volatility.
- Ranked lockup terms will make about 911.5 million shares eligible for sale after SpaceX’s first quarterly report, a large near‑term supply overhang that investors fear could push the price lower.
- SpaceX has pursued large, debt‑backed moves to fund AI and Starship work, including an all‑stock AI acquisition and reported note sales of roughly $20–25 billion, raising questions about near‑term funding needs.
- Underwriting banks issued tightly clustered, bullish price targets (median $225) while collecting roughly $500 million in fees, a pattern critics call copycat optimism that investors must weigh against SpaceX’s 2025 revenue of under $19 billion and a GAAP loss near $4.9 billion.